Results 231 to 240 of about 4,358,128 (358)
Molecular Mechanisms of Venom Diversity. [PDF]
Ishihara MA, Lopes AR, Nishiyama-Jr MY.
europepmc +1 more source
Molecular mechanism of sarcopenia
openaire +3 more sources
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain +10 more
wiley +1 more source
Advancements and innovations in the molecular mechanisms and treatment of colorectal cancer. [PDF]
Wang X, Yang J.
europepmc +1 more source
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu +10 more
wiley +1 more source
Editorial: Enhancing adrenal tumor diagnostics: biomarkers and molecular mechanisms. [PDF]
Glinicki P, Falhammar H.
europepmc +1 more source
Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley +1 more source
Special Issue: "Molecular Mechanisms and Regulation in Chronic Kidney Diseases". [PDF]
Delrue C, Delanghe JR, Speeckaert MM.
europepmc +1 more source

